Financial Consulate’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Buy
7,599
+41
+0.5% +$4.8K 0.11% 59
2026
Q1
$909K Sell
7,558
-1,145
-13% -$132K 0.11% 56
2025
Q4
$916K Sell
8,703
-164
-2% -$15.4K 0.13% 58
2025
Q3
$744K Buy
+8,867
New +$730K 0.11% 64
2023
Q2
Sell
-5,729
Closed -$610K 89
2023
Q1
$610K Sell
5,729
-2,508
-30% -$271K 0.21% 50
2022
Q4
$914K Sell
8,237
-200
-2% -$20.4K 0.32% 43
2022
Q3
$727K Sell
8,437
-383
-4% -$34.2K 0.31% 43
2022
Q2
$804K Sell
8,820
-404
-4% -$35.8K 0.38% 39
2022
Q1
$757K Buy
9,224
+973
+12% +$76.7K 0.29% 48
2021
Q4
$632K Buy
8,251
+21
+0.3% +$1.67K 0.22% 55
2021
Q3
$618K Buy
8,230
+6
+0.1% +$456 0.22% 52
2021
Q2
$640K Sell
8,224
-881
-10% -$65.5K 0.23% 51
2021
Q1
$670K Sell
9,105
-12
-0.1% -$885 0.27% 49
2020
Q4
$712K Sell
9,117
-419
-4% -$32K 0.31% 43
2020
Q3
$755K Sell
9,536
-372
-4% -$29.1K 0.36% 37
2020
Q2
$731K Sell
9,908
-337
-3% -$25.4K 0.37% 37
2020
Q1
$752K Buy
10,245
+17
+0.2% +$1.34K 0.45% 38
2019
Q4
$888K Buy
10,228
+99
+1% +$8.13K 0.39% 39
2019
Q3
$814K Buy
10,129
+1,274
+14% +$102K 0.35% 43
2019
Q2
$708K Buy
8,855
+2,216
+33% +$170K 0.32% 45
2019
Q1
$527K Buy
6,639
+145
+2% +$10.8K 0.24% 62
2018
Q4
$474K Buy
6,494
+35
+0.5% +$2.47K 0.28% 63
2018
Q3
$437K Hold
6,459
0.25% 75
2018
Q2
$374K Buy
6,459
+702
+12% +$39.6K 0.19% 79
2018
Q1
$299K Hold
5,757
0.16% 87
2017
Q4
$309K Sell
5,757
-387
-6% -$21.5K 0.16% 81
2017
Q3
$375K Buy
+6,144
New +$372K 0.2% 72

Other funds holding MRK

Financial Consulate's MRK Position: Q2 2026 in Review

Financial Consulate increased its Merck (MRK) stake by 0.54% in Q2 2026, buying an estimated $4.8K and bringing the position to 7,599 shares worth $978K. The position accounts for 0.11% of the portfolio, ranked #59.

Financial Consulate first reported a position in MRK in Q3 2017 and has held it in 27 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Financial Consulate held 7,599 shares of Merck worth $978K as of Q2 2026.
  • Financial Consulate bought 41 Merck shares in Q2 2026, an estimated $4.8K.
  • Merck made up 0.11% of Financial Consulate's portfolio in Q2 2026, its #59 holding.
  • Financial Consulate first reported a position in Merck in Q3 2017 and has held it in 27 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.